New combo therapy may offer lasting pain control for facial nerve condition
NCT ID NCT07304453
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a combination of nucleotides and B vitamins (Nucleo CMP and Neurorubine) could provide better and longer-lasting pain relief than the standard drug carbamazepine for people with trigeminal neuralgia, a severe facial pain condition. 38 adults with classic trigeminal neuralgia were randomly assigned to one of the two treatments. The goal was to see if the new combo could control pain during treatment and keep pain away after stopping it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nucleo CMP (cytidine monophosphate) and Neurorubine (vitamins B1, B6, B12)
What this could lead to
If it works, this could offer a new way to manage trigeminal neuralgia pain that lasts even after stopping treatment, potentially reducing side effects from standard drugs.
What could go wrong
This is a small Phase 2 trial with only 38 participants, so results may not apply to everyone. The combination therapy may not work better than carbamazepine, and its long-term safety is not yet fully known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oral Medicine Clinic, College of Dentistry, University of Kerbala
Karbala, Kerbala, Iraq